The publications on this site are part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726

Informa
Skip to Page Content

Companies

Search All Companies »

Find a Company by Name

View All Companies

All
Industries

Biotechnology

Email Alert | RSS Feed

Provention Bio Inc. / See Company Profile

Financing / Public offering nets $37.6mm for Provention Bio / Strategic Transactions / Deal Date: Sep. 1, 2019 / Publish Date: Sep. 23, 2019

Financing / Private placement from Amgen grosses $20mm for Provention / Strategic Transactions / Deal Date: Sep. 1, 2019 / Publish Date: Sep. 23, 2019

Alliance / Amgen partners celiac candidate with Provention Bio / Strategic Transactions / Deal Date: Nov. 1, 2018 / Update Date: Sep. 1, 2019

Anokion SA / See Company Profile

Acquisition / Anokion acquires Kanyos Bio / Strategic Transactions / Deal Date: Sep. 1, 2019 / Publish Date: Sep. 13, 2019

Financing / Series B round garners $40mm for Anokion concurrent with Kanyos acquisition / Strategic Transactions / Deal Date: Sep. 1, 2019 / Publish Date: Sep. 13, 2019

Alliance / Anokion allies with Astellas and forms Kanyos to develop compounds / Strategic Transactions / Deal Date: Jun. 1, 2015 / Update Date: Sep. 1, 2019

Amplyx Pharmaceuticals Inc. / See Company Profile

Alliance / Amplyx licenses global rights to Novartis' shelved MAU868 for BKV disease / Strategic Transactions / Deal Date: Sep. 1, 2019 / Publish Date: Sep. 20, 2019

Financing / Amplyx brings in $67mm via Series C / Strategic Transactions / Deal Date: Aug. 1, 2017 / Publish Date: Aug. 7, 2017

Financing / Series B lands $40.5mm for Amplyx; adds $8.7mm / Strategic Transactions / Deal Date: Nov. 1, 2015 / Update Date: Feb. 1, 2016


Medical Devices

Email Alert | RSS Feed

Attune Medical / See Company Profile

Alliance / Attune gets exclusive rights to Stanford IP / Strategic Transactions / Deal Date: Sep. 1, 2019 / Publish Date: Sep. 26, 2019

Financing / Series B raises $3mm for Advanced Cooling Therapy / Strategic Transactions / Deal Date: Jul. 1, 2015 / Publish Date: Sep. 5, 2018

Financing / Attune Medical closes $15.5mm Series C round / Strategic Transactions / Deal Date: Sep. 1, 2018 / Publish Date: Sep. 5, 2018

Integra LifeSciences Holdings Corp. / See Company Profile

Acquisition / Integra buys MIS single-use device maker Rebound / Strategic Transactions / Deal Date: Sep. 1, 2019 / Publish Date: Sep. 13, 2019

Financing / Integra LifeSciences nets $303.8mm through public offering / Strategic Transactions / Deal Date: May 1, 2018 / Publish Date: May 14, 2018

Acquisition / Integra to buy Codman Neurosurgery for over $1bn / Strategic Transactions / Deal Date: Feb. 1, 2017 / Update Date: Oct. 1, 2017

Stryker Corp. / See Company Profile

Alliance / Stryker gets IP from Conformis / Strategic Transactions / Deal Date: Oct. 1, 2019 / Publish Date: Oct. 11, 2019

Acquisition / Stryker acquires imaging device maker Mobius along with sister spinal robotics company Cardan / Strategic Transactions / Deal Date: Sep. 1, 2019 / Publish Date: Sep. 16, 2019

Acquisition / Stryker boosts surgical device sterilization offerings through buy of TSO3 / Strategic Transactions / Deal Date: Aug. 1, 2019 / Publish Date: Aug. 13, 2019


In Vitro Diagnostics

Email Alert | RSS Feed

Chembio Diagnostics Inc. / See Company Profile

Financing / Chembio enters $20mm term loan with Perceptive Advisors / Strategic Transactions / Deal Date: Sep. 1, 2019 / Publish Date: Sep. 11, 2019

Financing / Chembio nets $15mm via FOPO / Strategic Transactions / Deal Date: Nov. 1, 2018 / Publish Date: Nov. 2, 2018

Financing / Chembio Diagnostics nets $11.2mm via FOPO / Strategic Transactions / Deal Date: Feb. 1, 2018 / Publish Date: Feb. 14, 2018

HTG Molecular Diagnostics Inc. / See Company Profile

Financing / HTG brings in $21.2mm through public offering / Strategic Transactions / Deal Date: Sep. 1, 2019 / Publish Date: Sep. 24, 2019

Financing / HTG Molecular enters $30mm credit facility; gets $9mm up front / Strategic Transactions / Deal Date: Mar. 1, 2018 / Publish Date: Apr. 2, 2018

Financing / HTG Molecular nets $37.9mm through latest FOPO / Strategic Transactions / Deal Date: Jan. 1, 2018 / Publish Date: Jan. 23, 2018


Pharmaceuticals

Email Alert | RSS Feed

Proteon Therapeutics Inc. / See Company Profile

Financing / Upon close of ArTara/Proteon merger, investors to provide $42.5mm in funding / Strategic Transactions / Deal Date: Sep. 1, 2019 / Publish Date: Sep. 27, 2019

Acquisition / ArTara, Proteon merge / Strategic Transactions / Deal Date: Sep. 1, 2019 / Publish Date: Sep. 24, 2019

Financing / Proteon grosses $22mm through private preferred share sale / Strategic Transactions / Deal Date: Jun. 1, 2017 / Publish Date: Jul. 7, 2017

PTC Therapeutics Inc. / See Company Profile

Financing / PTC Therapeutics sells $250mm in convertible debt financing / Strategic Transactions / Deal Date: Sep. 1, 2019 / Publish Date: Sep. 20, 2019

Financing / PTC Therapeutics nets $97.3mm via FOPO / Strategic Transactions / Deal Date: Sep. 1, 2019 / Publish Date: Sep. 20, 2019

Alliance / PTC gets two rare disease therapies from Akcea / Strategic Transactions / Deal Date: Aug. 1, 2018 / Update Date: May 1, 2019

Castle Creek Pharmaceuticals LLC / See Company Profile

Acquisition / Castle Creek buys EB partner Fibrocell for $63mm / Strategic Transactions / Deal Date: Sep. 1, 2019 / Publish Date: Sep. 20, 2019

Alliance / Castle Creek licenses US rights to Fibrocell's FCX007 RDEB gene therapy candidate for up to $135mm / Strategic Transactions / Deal Date: Apr. 1, 2019 / Publish Date: Apr. 17, 2019

Alliance / Castle Creek licenses US rights to Hennig's Arlevert / Strategic Transactions / Deal Date: Dec. 1, 2016 / Publish Date: Dec. 16, 2016

Biotechnology

Biotechnology

Email Alert | RSS Feed

Provention Bio Inc. / See Company Profile

Financing / Public offering nets $37.6mm for Provention Bio / Strategic Transactions / Deal Date: Sep. 1, 2019 / Publish Date: Sep. 23, 2019

Financing / Private placement from Amgen grosses $20mm for Provention / Strategic Transactions / Deal Date: Sep. 1, 2019 / Publish Date: Sep. 23, 2019

Alliance / Amgen partners celiac candidate with Provention Bio / Strategic Transactions / Deal Date: Nov. 1, 2018 / Update Date: Sep. 1, 2019

Anokion SA / See Company Profile

Acquisition / Anokion acquires Kanyos Bio / Strategic Transactions / Deal Date: Sep. 1, 2019 / Publish Date: Sep. 13, 2019

Financing / Series B round garners $40mm for Anokion concurrent with Kanyos acquisition / Strategic Transactions / Deal Date: Sep. 1, 2019 / Publish Date: Sep. 13, 2019

Alliance / Anokion allies with Astellas and forms Kanyos to develop compounds / Strategic Transactions / Deal Date: Jun. 1, 2015 / Update Date: Sep. 1, 2019

Amplyx Pharmaceuticals Inc. / See Company Profile

Alliance / Amplyx licenses global rights to Novartis' shelved MAU868 for BKV disease / Strategic Transactions / Deal Date: Sep. 1, 2019 / Publish Date: Sep. 20, 2019

Financing / Amplyx brings in $67mm via Series C / Strategic Transactions / Deal Date: Aug. 1, 2017 / Publish Date: Aug. 7, 2017

Financing / Series B lands $40.5mm for Amplyx; adds $8.7mm / Strategic Transactions / Deal Date: Nov. 1, 2015 / Update Date: Feb. 1, 2016

Medical
Devices

Medical Devices

Email Alert | RSS Feed

Attune Medical / See Company Profile

Alliance / Attune gets exclusive rights to Stanford IP / Strategic Transactions / Deal Date: Sep. 1, 2019 / Publish Date: Sep. 26, 2019

Financing / Series B raises $3mm for Advanced Cooling Therapy / Strategic Transactions / Deal Date: Jul. 1, 2015 / Publish Date: Sep. 5, 2018

Financing / Attune Medical closes $15.5mm Series C round / Strategic Transactions / Deal Date: Sep. 1, 2018 / Publish Date: Sep. 5, 2018

Integra LifeSciences Holdings Corp. / See Company Profile

Acquisition / Integra buys MIS single-use device maker Rebound / Strategic Transactions / Deal Date: Sep. 1, 2019 / Publish Date: Sep. 13, 2019

Financing / Integra LifeSciences nets $303.8mm through public offering / Strategic Transactions / Deal Date: May 1, 2018 / Publish Date: May 14, 2018

Acquisition / Integra to buy Codman Neurosurgery for over $1bn / Strategic Transactions / Deal Date: Feb. 1, 2017 / Update Date: Oct. 1, 2017

Stryker Corp. / See Company Profile

Alliance / Stryker gets IP from Conformis / Strategic Transactions / Deal Date: Oct. 1, 2019 / Publish Date: Oct. 11, 2019

Acquisition / Stryker acquires imaging device maker Mobius along with sister spinal robotics company Cardan / Strategic Transactions / Deal Date: Sep. 1, 2019 / Publish Date: Sep. 16, 2019

Acquisition / Stryker boosts surgical device sterilization offerings through buy of TSO3 / Strategic Transactions / Deal Date: Aug. 1, 2019 / Publish Date: Aug. 13, 2019

In Vitro
Diagnostics

In Vitro Diagnostics

Email Alert | RSS Feed

Chembio Diagnostics Inc. / See Company Profile

Financing / Chembio enters $20mm term loan with Perceptive Advisors / Strategic Transactions / Deal Date: Sep. 1, 2019 / Publish Date: Sep. 11, 2019

Financing / Chembio nets $15mm via FOPO / Strategic Transactions / Deal Date: Nov. 1, 2018 / Publish Date: Nov. 2, 2018

Financing / Chembio Diagnostics nets $11.2mm via FOPO / Strategic Transactions / Deal Date: Feb. 1, 2018 / Publish Date: Feb. 14, 2018

HTG Molecular Diagnostics Inc. / See Company Profile

Financing / HTG brings in $21.2mm through public offering / Strategic Transactions / Deal Date: Sep. 1, 2019 / Publish Date: Sep. 24, 2019

Financing / HTG Molecular enters $30mm credit facility; gets $9mm up front / Strategic Transactions / Deal Date: Mar. 1, 2018 / Publish Date: Apr. 2, 2018

Financing / HTG Molecular nets $37.9mm through latest FOPO / Strategic Transactions / Deal Date: Jan. 1, 2018 / Publish Date: Jan. 23, 2018

Pharmaceuticals

Pharmaceuticals

Email Alert | RSS Feed

Proteon Therapeutics Inc. / See Company Profile

Financing / Upon close of ArTara/Proteon merger, investors to provide $42.5mm in funding / Strategic Transactions / Deal Date: Sep. 1, 2019 / Publish Date: Sep. 27, 2019

Acquisition / ArTara, Proteon merge / Strategic Transactions / Deal Date: Sep. 1, 2019 / Publish Date: Sep. 24, 2019

Financing / Proteon grosses $22mm through private preferred share sale / Strategic Transactions / Deal Date: Jun. 1, 2017 / Publish Date: Jul. 7, 2017

PTC Therapeutics Inc. / See Company Profile

Financing / PTC Therapeutics sells $250mm in convertible debt financing / Strategic Transactions / Deal Date: Sep. 1, 2019 / Publish Date: Sep. 20, 2019

Financing / PTC Therapeutics nets $97.3mm via FOPO / Strategic Transactions / Deal Date: Sep. 1, 2019 / Publish Date: Sep. 20, 2019

Alliance / PTC gets two rare disease therapies from Akcea / Strategic Transactions / Deal Date: Aug. 1, 2018 / Update Date: May 1, 2019

Castle Creek Pharmaceuticals LLC / See Company Profile

Acquisition / Castle Creek buys EB partner Fibrocell for $63mm / Strategic Transactions / Deal Date: Sep. 1, 2019 / Publish Date: Sep. 20, 2019

Alliance / Castle Creek licenses US rights to Fibrocell's FCX007 RDEB gene therapy candidate for up to $135mm / Strategic Transactions / Deal Date: Apr. 1, 2019 / Publish Date: Apr. 17, 2019

Alliance / Castle Creek licenses US rights to Hennig's Arlevert / Strategic Transactions / Deal Date: Dec. 1, 2016 / Publish Date: Dec. 16, 2016

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel